GANGLIONEUROMA

GANGLIONEUROMA was reported 66 times

GANGLIONEUROMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Glycolipid Disialoganglioside-directed Antibody [EPC] 1 0.0009
1 Purine Antimetabolite [EPC] 12 0.0001
2 Topoisomerase Inhibitor [EPC] 9 0.0001
3 Alkylating Drug [EPC] 21 0.0001
4 Aminosalicylate [EPC] 7 0.0001
5 Platinum-based Drug [EPC] 16 0.0001
6 Recombinant Human Growth Hormone [EPC] 1 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 18 0.0000
8 Alkaloid [EPC] 1 0.0000
9 Provitamin D2 Compound [EPC] 1 0.0000
10 CD20-directed Cytolytic Antibody [EPC] 10 0.0000
11 Interleukin-17A Antagonist [EPC] 1 0.0000
12 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
13 Tetracycline-class Drug [EPC] 1 0.0000
14 Calcium [EPC] 2 0.0000
15 Corticosteroid [EPC] 15 0.0000
16 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
17 Tumor Necrosis Factor Blocker [EPC] 11 0.0000
18 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
19 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
20 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
21 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
22 Leukocyte Growth Factor [EPC] 1 0.0000
23 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
24 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
25 RANK Ligand Inhibitor [EPC] 1 0.0000
26 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
27 Atypical Antipsychotic [EPC] 1 0.0000
28 Loop Diuretic [EPC] 1 0.0000
29 Thalidomide Analog [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
32 Benzodiazepine [EPC] 1 0.0000